Here's What Investors Need to Know About Johnson & Johnson's Split

Last month, pharmaceutical giant Johnson & Johnson (NYSE: JNJ) announced a change that investors never saw coming. The company plans to split its pharmaceutical and medical device business from its legacy consumer health business. Fool contributors Rachel Warren and Toby Bordelon discuss the terms of the split in this segment of Backstage Pass, recorded on Nov. 19. 

Continue reading

Source Fool.com